undamentalytics Newsletter
Sign in

Neidig Brent: insider trades

Officer at Usana Health Sciences Inc. No open-market purchases and 14 sales not made under a pre-set plan, reported from February 10, 2020 to June 18, 2026.

What happened after Neidig Brent’s sales?

After their sales, the shares moved −32.5% against the index over 12 months on average (a negative figure means selling was the right call); 92% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 14 −10.2% −12.2% 79% 7 −3.08 0.022 Some evidence: seller right
Sales, 12 months after the report 12 −32.5% −33.1% 92% 6 −6.19 0.002 Strong evidence: seller right
Sales, 12 months after the trade 12 −33.6% −33.5% 100% 6 −5.74 0.002 Strong evidence: seller right

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Usana Health Sciences Inc USNA CHIEF COMMERCIAL OFFICER014February 10, 2020June 18, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
June 18, 2026June 16, 2026 USNA Sale $97,289 −27.5%not yetnot yet
June 16, 2026June 12, 2026 USNA Sale $50,469 −25.3%not yetnot yet
March 13, 2025March 12, 2025 USNA Sale $153,389 −5.0%−60.0%−66.6%
March 7, 2024March 6, 2024 USNA Sale $179,070 −6.9%−43.7%−41.9%
May 9, 2023May 5, 2023 USNA Sale $180,390 −6.7%−56.3%−60.5%
February 10, 2023February 9, 2023 USNA Sale $115,858 +6.3%−42.3%−40.5%
June 17, 2022June 16, 2022 USNA Sale $99,302 −20.7%−33.9%−34.8%
November 8, 2021November 5, 2021 USNA Sale $18,004 −13.4%−32.4%−32.3%
June 21, 2021June 18, 2021 USNA Sale $26,462 −16.4%−17.9%−19.4%
February 16, 2021February 12, 2021 USNA Sale $185,554 +4.1%−19.2%−16.3%
October 27, 2020October 26, 2020 USNA Sale $14,842 −11.0%−24.7%−18.6%
August 14, 2020August 13, 2020 USNA Sale $21,778 −16.6%−19.7%−21.0%
April 29, 2020April 27, 2020 USNA Sale $155,177 −20.8%−45.1%−37.3%
February 10, 2020February 6, 2020 USNA Sale $176,167 +17.4%+4.9%−13.9%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Neidig Brent traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.